Eradication of H. Pylori Therapy Individualized by the Mutation of 23S rRNA of H. Pylori

• Status: Unknown status
• Trial end date: 2018-05-01
• Target enrollment: 0
• Participant gender: All

Summary

Patients infected with H. pylori are treated with the individualized regimen which is based on the mutation of 23S rRNA of H. pylori.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hamamatsu University
• Treatments: Amoxicillin; Clarithromycin

Criteria

Inclusion Criteria:

• Patients infected with H. pylori are invited to the study.

• Patients not allergic to the any of the drugs used for eradication of H. pylori.

• Patients who has agreed to participate to the study.

Exclusion Criteria:

• Patients allergic to the any of the drugs used for eradication of H. pylori.

• Patients who do not agree to the study.